// App-Quantinova.ai

T1147 2015 AHA : Myocardial Replenishment of Tissue Inhibitor of Metalloproteinase (TIMP)-3 and TIMP4 Following Myocardial Infarction Result in Differential Protective Effects

Researchers

Presenter

  • Ratnadeep Basu

Principal Investigators

  • Xiuhua Wang

  • Zamaneh Kassiri

Medical Centers

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Congestive heart failure

  • Heart muscle disease

Biomarkers

  • Galectin-3

Drug/Treatment

  • TIMP-3 secretion inducer

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim